Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872027 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 10 Pages |
Abstract
Conclusion: This ex-ante cost evaluation of IM-MS RT showed that the upfront costs of locoregional RT are easily compensated for by avoiding the costs of treating locoregional and distant relapse at a later stage. The cost-sparing effect of RT should, however, be evaluated for a sufficiently long time span and is most specifically found in tumors with a rather slow natural history and a multitude of available systemic treatments at relapse, such as breast cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yolande M.D., Ph.D., Katrien Ph.D., Walter M.D., Ph.D.,